ClinicalTrials.Veeva

Menu

High-Flow Tracheal Therapy on Tracheobronchial Secretions in Tracheostomized Patients (TRACH2O)

C

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Status

Not yet enrolling

Conditions

Tracheostomized Patients

Treatments

Device: High-Flow Tracheal Therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT06897319
TRACH2O

Details and patient eligibility

About

This monocentric, randomized crossover study aims to assess the impact of high-flow tracheal therapy (HFT) on the rheological properties of tracheobronchopulmonary secretions in tracheostomized patients. The primary objective is to compare the viscoelastic characteristics of secretions collected with and without HFT. Secondary objectives include evaluating the effects of HFT on dyspnea, patient comfort, and secretion appearance. The study will take place at Cliniques Universitaires Saint-Luc, with adult tracheostomized patients undergoing standard care.

Enrollment

15 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients (≥18 years old)
  • Tracheostomized patients
  • Patients requiring routine tracheal suctioning and already using HFT overnight

Exclusion criteria

  • Insufficient secretions for analysis
  • Cognitive impairment or confusion

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

15 participants in 2 patient groups

HFT
Experimental group
Treatment:
Device: High-Flow Tracheal Therapy
Control
No Intervention group

Trial contacts and locations

1

Loading...

Central trial contact

William Poncin

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems